Targeting cytokine storm as the potential anti-viral therapy: Implications in regulating SARS-CoV-2 pathogenicity

Subhasish Maity1, Ayantika Santra2, Ananda Vardhan Hebbani2

  • 1Department of Biotechnology, REVA University, Bengaluru 560064, Karnataka, India.

Gene
|July 9, 2023
PubMed

Insights

The COVID-19 pandemic, caused by SARS-CoV-2, presents a significant global health challenge. This review explores targeting the dangerous cytokine storm associated with severe COVID-19, crucial for effective therapeutic strategies.

Area of Science:

  • Immunology
  • Virology
  • Infectious Diseases

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, remains a major global health concern.
  • COVID-19 is highly contagious and exhibits a wide range of symptom severities.
  • A 'cytokine storm,' characterized by elevated cytokine levels, is linked to severe COVID-19 progression.

Purpose of the Study:

  • To review the potential of targeting the cytokine storm in COVID-19.
  • To differentiate COVID-19-associated cytokine storm from normal immune responses.
  • To identify challenges in developing therapeutic strategies for cytokine storm.

Main Methods:

  • This is a review article, synthesizing existing research.
  • Focuses on understanding the mechanisms of cytokine storm in COVID-19.
  • Examines potential therapeutic targets and their associated challenges.

Main Results:

  • Severe COVID-19 is associated with elevated levels of specific cytokines (e.g., IL-6, TNF-γ).
  • Cytokine storm contributes to disease escalation from mild to severe.
  • Understanding this phenomenon is key to effective treatment.

Conclusions:

  • Targeting the cytokine storm is a promising therapeutic avenue for severe COVID-19.
  • Differentiating pathological cytokine storms from beneficial immune responses is critical.
  • Further research is needed to overcome challenges in developing targeted therapies.